Skip to main content
Signal8

Adaptimmune Therapeutics PLC (ADAPY)

Adaptimmune Therapeutics plc is a commercial-stage biopharmaceutical company specializing in innovative cell therapies for cancer patients, primarily operating in the United States and the United Kingdom. Its pipeline includes TECELRA (also known as famitresgene autoleucel or afami-cel), an autologous T-cell immunotherapy that employs genetically modified cells to treat adults with advanced, unresectable, or metastatic synovial sarcoma. The company is also advancing Lete-cel for synovial sarcoma and myxoid liposarcoma, and ADP-5701, currently in Phase 1 clinical trials for head and neck cancer. Additionally, Adaptimmune is developing T-cell therapies engineered to target PRAME (ADP-600) and CD70 (ADP-520). The firm engages in strategic collaborations, notably with Galapagos for a clinical proof-of-concept trial of uza-cel (ADP-5701) in head and neck cancer, leveraging Galapagos' decentralized manufacturing platform. Further partnerships include a licensing agreement with Noile-Immune Biotech, Inc. and a strategic alliance with the MD Anderson Cancer Center. Established in 2008, Adaptimmune Therapeutics plc is headquartered in Abingdon, United Kingdom.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Adaptimmune Therapeutics plc logo

Adaptimmune Therapeutics plc

OTC:ADAPYHealthcare
-16.33%$0.0251
Mkt Cap-
Float265.01M
O/S-
Inst Own-
SI0.5%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$5.92M
Net Income$25.21M
Total Assets$63.36M
Free Cash Flow-$75.93M
Debt & Equity
Debt 31%
Equity 69%
Total Debt$14.08M
Total Equity$31.97M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in ADAPY's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$63.36M
Liabilities$31.39M
Accounts Receivable$6.99M
Accounts Payable$16.61M
Inventory$0
PP&E (Net)$16.29M
Goodwill$0
Intangible Assets$22K
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-06-302014-06-302013-06-30
Revenue$5.92M$178.03M$60.28M$27.15M$6.15M$3.96M$1.12M$59.51M$37.83M$14.2M$10.72M$605K$0
YoY Growth-96.7%195.3%122.0%341.5%55.4%252.8%-98.1%57.3%166.5%32.4%1673.2%--
Cost of Revenue$0$70K$9.86M$127.73M$111.09M$91.57M$97.5M$0$0$0$0$0$0
Gross Profit$5.92M$177.96M$50.42M-$100.58M-$104.94M-$87.61M-$96.38M$59.51M$37.83M$14.2M$10.72M$605K$0
Gross Margin100.0%100.0%83.6%-370.5%-1706.6%-2213.5%-8589.9%100.0%100.0%100.0%100.0%100.0%-
Research and Development$47.99M$149.06M$126.51M$127.73M$111.09M$91.57M$97.5M$98.27M$87.39M$63.79M$23.19M$12.53M$8.15M
Selling, General, and Administrative$35.62M$81.31M$71.81M$63.39M$57.3M$45.8M$43.39M$43.6M$31.11M$23.21M$11.32M$2.73M$1.21M
Other-$5.12M$16.35M$1.7M-$536K$3.85M$1.16M$75K$0$0$0-$726K-$281K$0
Total Operating Expenses$78.5M$246.72M$188.42M$191.11M$168.4M$137.36M$140.89M$141.87M$118.49M$87M$33.79M$14.98M$9.35M
Operating Income (EBIT)-$72.57M-$68.76M-$138.04M-$163.97M-$162.25M-$133.41M-$139.77M-$82.36M-$80.66M-$72.8M-$23.07M-$14.37M-$9.35M
Operating Margin-1225.1%-38.6%-229.0%-604.0%-2638.6%-3370.5%-12457.2%-138.4%-213.2%-512.7%-215.2%-2376.9%-
Interest Expense$0$3.35M$0$0$0$0$0$0$0$0$0$7K$7K
Interest Income$0$6.6M$5.96M$1.54M$1.09M$2.31M$2.77M$2.85M$2.23M$1.11M$787K$3K$0
Other Income (Expense)-$5.43M$1.49M$25.5M-$1.29M$4.95M$3.48M$2.85M-$12.65M$10.97M$2.11M-$3.19M$2.83M-$5K
Income Before Tax (EBT)-$78.01M-$67.27M-$112.53M-$162.96M-$157.3M-$129.93M-$136.92M-$95.02M-$69.69M-$70.69M-$23.69M-$14.37M-$9.34M
Income Tax Expense$0$3.58M$1.34M$2.5M$791K$162K$242K$497K$451K$892K-$2.11M-$1.67M-$879K
Net Income$25.21M-$70.81M-$113.87M-$165.46M-$158.09M-$130.09M-$137.16M-$95.51M-$70.14M-$71.58M-$21.59M-$12.7M-$8.46M
Net Income Margin425.5%-39.8%-188.9%-609.5%-2571.0%-3286.8%-12225.0%-160.5%-185.4%-504.1%-201.4%-2100.8%-
Supplementary Data
EPS-0.30-0.28-0.57-1.02-1.02-0.90-1.32-0.96-0.78-1.02-0.60-0.25-0.50
Diluted EPS-0.30-0.28-0.57-1.02-1.02-0.90-1.32-0.96-0.78-1.02-0.60-0.25-0.50
Weighted Average OS84.02M252.30M201.07M161.21M155.81M142.46M104.97M97.39M87.94M70.79M35.78M50.72M16.86M
EBITDA-$57.49M-$52.66M-$128.59M-$155.59M-$155.68M-$125.81M-$131.76M-$74.56M-$75.24M-$69.51M-$23.77M-$23.91M-$11.28M
EBITDA Margin-970.5%-29.6%-213.3%-573.1%-2531.8%-3178.7%-11743.3%-125.3%-198.9%-489.6%-221.7%-3953.9%-
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-06-302014-06-302013-06-302012-06-30
Assets
Current Assets
Cash and Cash Equivalents$25.95M$91.14M$143.99M$108.03M$149.95M$56.88M$50.41M$68.38M$84.04M$158.78M$229.06M$51.27M$248K$3.02M
Short-Term Investments$0$60.47M$2.95M$96.57M$219.63M$311.33M$39.13M$136.75M$124.22M$22.69M$55.3M$0$0$0
Cash and Short-Term Investments$25.95M$151.6M$146.94M$204.6M$369.58M$368.22M$89.54M$205.13M$208.26M$181.47M$284.36M$51.27M$248K$3.02M
Accounts Receivable$6.99M$15.98M$46.92M$38.09M$34.01M$20.72M$19.28M$16.65M$11.66M$7.73M$5.45M$4K$27K$680K
Inventory$0$7.32M$0$0$0$0$1.46M$1.09M$3.76M$1.19M$102K$0$2$0
Other Current Assets$9.46M$3.23M$3.74M$3.21M$2.83M$2.9M$1.81M$25.77M$17.96M$14.61M$102K$5.43M$442K$163K
Total Current Assets$45.31M$188.17M$207.55M$255.37M$415.46M$398.15M$120.49M$231.09M$230.18M$198.75M$295.11M$54.09M$1.6M$3.87M
Long-Term Assets
Property, Plant & Equipment Net$16.29M$51.22M$71.71M$71.53M$51.37M$46.66M$51.86M$36.12M$40.68M$27.9M$5.39M$1.43M$208K$97K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$22K$3.88M$330K$442K$1M$1.73M$2.2M$1.47M$1.34M$1.27M$178K$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$4.1M$4.25M$4.02M$4.48M$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0-$4.1M-$4.25M-$4.02M-$9.19M$0$0$0
Other Long-Term Assets$1.73M$2.7M$3.03M$1.57M$1.72M$4.6M$7M$8.05M$8.95M$6.6M$4.71M$0$0$0
Total Long-Term Assets$18.05M$57.79M$75.06M$73.55M$54.09M$52.99M$61.05M$45.64M$50.96M$35.76M$5.57M$1.43M$208K$97K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$63.36M$245.96M$282.62M$328.92M$469.55M$451.14M$181.54M$276.74M$281.15M$234.51M$300.68M$55.52M$1.81M$3.96M
Liabilities
Current Liabilities
Accounts Payable$16.61M$8.69M$8.13M$4.75M$8.11M$6.39M$6.36M$4.08M$8.38M$11.35M$7.84M$1.98M$1.02M$1.87M
Short-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$1.54M$1.54M
Current Income Tax Payable$0$0$1.4M$0$0$0$0$0$5.74M$2.01M$288K$8.5M$41K$28K
Current Unearned Revenue$0$12.3M$28.97M$23.52M$22.2M$2.83M$2.13M$0$38.73M$11.39M$20.91M$0$0-$1.54M
Other Current Liabilities$696K$21.46M$15.68M$25.27M$18.15M$15.25M$16.5M$12.8M$6.95M$10.97M$3.87M$40K$40.57M$170K
Total Current Liabilities$22.23M$64.53M$72.79M$64.5M$62.54M$39.07M$34.34M$24.44M$74.31M$40.27M$26.76M$53.11M$3.97M$4.09M
Long-Term Liabilities
Long-Term Debt$0$50.24M$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$95.81M$149.06M$160.89M$177.22M$49.26M-$3.69M$0$0$24.96M$26.49M$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$3.69M$1.42M$2.16M$0$0$0$0$0
Other Long-Term Liabilities$0$4.27M$1.4M$1.3M$673K$644K$598K$5.41M$3.85M$3.14M-$12.18M$0$0$0
Total Long-Term Liabilities$9.15M$169.59M$170.31M$182.54M$201.04M$70.84M$23.56M$5.41M$3.85M$28.1M$14.31M$1.01M$3.45M$556K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0-$1.01M-$3.45M-$556K
Total Liabilities$31.39M$234.11M$243.1M$247.04M$263.58M$109.92M$57.91M$29.85M$78.16M$68.37M$41.07M$53.11M$3.97M$4.09M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$1$1$0$0
Common Stock$2.16M$2.08M$1.86M$1.4M$1.34M$1.32M$943K$939K$854K$683K$668K$3K$2K$2K
Retained Earnings-$914.45M-$1.09B-$1.02B-$909.3M-$743.85M-$585.76M-$455.66M-$318.5M-$231.63M-$161.49M-$47.16M-$32.26M-$17.64M-$9.66M
Comprehensive Income & Other$114.28M-$1.9M-$3.75M-$875K-$11.14M-$10.05M-$7.26M-$9.76M-$21.64M-$14.25M$126.69M$187K-$47K-$8K
Other Stockholders' Equity$944.26M$1.1B$1.06B$989.78M$948.47M$925.66M$578.36M$564.45M$433.76M$326.95M$306.1M$34.67M$15.49M$9.53M
Total Equity$31.97M$11.85M$39.51M$81.88M$205.96M$341.23M$123.64M$246.88M$202.98M$166.14M$259.61M$2.41M-$2.16M-$126K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$63.36M$245.96M$282.62M$328.92M$469.55M$451.14M$181.54M$276.74M$281.15M$234.51M$300.68M$55.52M$1.81M$3.96M
Supplementary Data
Total Debt$14.08M$74.21M$25.23M$23.08M$25.47M$23.71M$25.46M$136.75M$124.22M$0$0$0$1.54M$1.54M
Net Debt-$11.87M-$16.93M-$118.76M-$84.96M-$124.48M-$33.17M-$24.95M$68.38M$40.17M-$158.78M-$229.06M-$51.27M$1.29M-$1.49M
Cash Flow Statement
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-06-302014-06-302013-06-30
Operating Activities
Net Income-$70.81M-$113.87M-$165.46M-$158.09M-$130.09M-$137.16M-$95.51M-$70.14M-$71.58M-$23.69M-$14.37M-$9.34M
Depreciation & Amortization$11.22M$9.45M$6.08M$6.57M$7.59M$8.01M$7.81M$5.42M$3.29M$733K$250K$46K
Deferred Income Tax$0$0$0$5.82M$0$1.06M$12.22M-$7.95M$0$0$1.22M-$0
Stock-Based Compensation$12.05M$11.77M$18.24M$20.63M$10.41M$11.05M$0$10.8M$8.82M$4.22M$349K$170K
Changes in Working Capital:
  Accounts Receivable$29.77M-$1.29M-$9.81M-$19.36M$1.76M-$1.44M$0$0$0$0$0$0
  Inventory-$7.36M$0$5.4M$15.15M$0-$6.19M$0$0$0$0$0$0
  Accounts Payable$9.62M$0$4.41M$4.21M$0$7.63M$0$0$0$0$0$0
  Other Working Capital-$69.04M-$25.05M-$1.53M$134.63M$50.82M$4.72M-$45.34M$7.21M$12.5M-$13.74M$49.78M$905K
Total Working Capital Change-$36.99M-$24.95M-$1.53M$134.62M$56.05M$4.72M-$45.34M$7.21M$12.5M-$13.74M$49.78M$905K
Other Non-Cash Items$11.33M-$23.28M$903K$1.19M$2.45M-$185K$237K$341K-$1.19M-$258K$2K$458K
Net Cash from Operating-$73.21M-$140.88M-$141.77M$10.73M-$53.59M-$112.51M-$104.39M-$54.31M-$48.17M-$32.74M$37.23M-$7.77M
Investing Activities
Capital Expenditures-$2.72M-$4.68M-$29.74M-$8.57M-$2.93M-$3.07M-$4.71M-$25.01M-$12.79M-$5.11M-$1.45M-$160K
Acquisitions$0$45.26M$77.86M$207K$0$1.48M$798K$369K$1.28M$0$0$0
Purchases of Investments-$100.42M-$75.95M-$48.12M-$139.75M-$381.04M-$27.28M-$150.79M-$171.33M-$42.84M-$55.3M$0$0
Sales of Investments$44.06M$210.98M$166.89M$224.32M$105.02M$125.3M$138.04M$69.72M$73.38M$0$0$0
Other Investing Activities$130K$1.13M-$77.86M-$207K-$565K-$1.48M-$798K$181K-$1.28M$124K$0$0
Net Cash from Investing-$58.95M$176.54M$89.14M$75.8M-$278.92M$94.94M-$17.46M-$126.08M$17.75M-$60.28M-$1.45M-$160K
Financing Activities
Debt Repaid-$49.5M-----------
Common Stock Issuance$29.17M$624K$12.82M$2.53M$334.39M$368K$99.65M$103.17M$0$0$175.99M$15.81M
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$77K$256K$50K$759K$5.66M$366K$3.04M$401K$17K$175.99M-$257.92M-$10.81M
Net Cash from Financing$78.75M$880K$12.87M$3.29M$340.05M$366K$102.69M$103.57M$17K$0$16.94M$3.71M
Forex Effect-$402K$877K-$2.3M$365K-$960K-$372K$3.33M$2.33M-$5.58M-$0-$0$2K
Net Change in Cash-$53.81M$37.41M-$42.06M$90.18M$6.58M-$17.57M-$15.82M-$74.5M-$35.98M$181.72M$52.72M-$4.22M
Supplementary Data
Operating Cash Flow-$73.21M-$140.88M-$141.77M$10.73M-$53.59M-$112.51M-$104.39M-$54.31M-$48.17M-$32.74M$37.23M-$7.77M
Capital Expenditure-$2.72M-$4.88M-$29.74M-$8.78M-$2.91M-$3.07M-$4.71M-$25.01M-$12.79M-$5.11M-$1.45M-$160K
Free Cash Flow-$75.93M-$145.76M-$171.51M$1.95M-$56.5M-$115.58M-$109.1M-$79.33M-$60.95M-$37.85M$35.78M-$7.92M
Cash at Beginning$147.02M$109.6M$151.67M$61.48M$54.91M$72.48M$88.3M$162.8M$198.77M$47.34M-$1.44M$2.93M
Cash at End$93.21M$147.02M$109.6M$151.67M$61.48M$54.91M$72.48M$88.3M$162.8M$229.06M$51.27M-$1.29M